58.48
price down icon0.15%   -0.09
pre-market  プレマーケット:  58.50   0.02   +0.03%
loading
前日終値:
$58.57
開ける:
$58.43
24時間の取引高:
4.33M
Relative Volume:
1.34
時価総額:
$7.42B
収益:
$638.78M
当期純損益:
$-22.66M
株価収益率:
-335.32
EPS:
-0.1744
ネットキャッシュフロー:
$122.18M
1週間 パフォーマンス:
+22.19%
1か月 パフォーマンス:
+36.86%
6か月 パフォーマンス:
+205.38%
1年 パフォーマンス:
+375.06%
1日の値動き範囲:
Value
$57.26
$60.69
1週間の範囲:
Value
$44.39
$60.69
52週間の値動き範囲:
Value
$11.16
$60.69

10 X Genomics Inc Stock (TXG) Company Profile

Name
名前
10 X Genomics Inc
Name
セクター
Healthcare (1079)
Name
電話
(925) 401-7300
Name
住所
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Name
職員
1,178
Name
Twitter
@10xgenomics
Name
次回の収益日
2026-08-06
Name
最新のSEC提出書
Name
TXG's Discussions on Twitter

Compare TXG vs VEEV, BTSG, TEM, HQY

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
TXG icon
TXG
10 X Genomics Inc
58.48 5.83B 638.78M -22.66M 122.18M -0.1744
VEEV icon
VEEV
Veeva Systems Inc
236.58 31.59B 3.32B 941.65M 1.64B 5.6161
BTSG icon
BTSG
Brightspring Health Services Inc
57.89 14.13B 13.65B 169.86M 412.12M 1.0758
TEM icon
TEM
Tempus Ai Inc
55.69 7.73B 1.36B -302.91M -219.93M -1.7182
HQY icon
HQY
Healthequity Inc
105.57 8.28B 1.34B 230.70M 440.96M 2.6695

10 X Genomics Inc Stock (TXG) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-03-31 アップグレード William Blair Mkt Perform → Outperform
2025-12-11 ダウングレード Citigroup Buy → Neutral
2025-12-02 ダウングレード Morgan Stanley Overweight → Equal-Weight
2025-09-11 開始されました Piper Sandler Neutral
2025-02-13 ダウングレード Leerink Partners Outperform → Market Perform
2024-09-03 開始されました Leerink Partners Outperform
2024-07-22 アップグレード Jefferies Hold → Buy
2024-07-18 ダウングレード JP Morgan Overweight → Neutral
2024-07-10 ダウングレード Deutsche Bank Buy → Hold
2024-06-27 ダウングレード Wolfe Research Outperform → Peer Perform
2024-06-25 ダウングレード Guggenheim Buy → Neutral
2024-06-03 再開されました Jefferies Hold
2024-05-01 ダウングレード TD Cowen Buy → Hold
2023-12-14 開始されました Guggenheim Buy
2023-12-13 開始されました Wolfe Research Outperform
2023-12-12 アップグレード BofA Securities Underperform → Neutral
2023-07-05 再開されました JP Morgan Overweight
2023-05-10 開始されました Barclays Overweight
2023-03-31 開始されました Stephens Overweight
2023-02-02 開始されました UBS Neutral
2022-12-14 開始されました Deutsche Bank Buy
2022-08-18 ダウングレード Goldman Neutral → Sell
2022-07-25 開始されました Canaccord Genuity Buy
2022-07-15 ダウングレード BofA Securities Neutral → Underperform
2022-07-15 ダウングレード William Blair Outperform → Mkt Perform
2021-10-15 再開されました Cowen Outperform
2021-09-14 ダウングレード BofA Securities Buy → Neutral
2021-03-15 開始されました William Blair Outperform
2020-12-02 開始されました Goldman Neutral
2020-09-09 開始されました Morgan Stanley Overweight
2020-07-10 開始されました Stifel Buy
2020-03-05 開始されました Guggenheim Buy
2020-01-07 開始されました Citigroup Buy
2019-10-07 開始されました BofA/Merrill Buy
2019-10-07 開始されました Cowen Outperform
2019-10-07 開始されました JP Morgan Overweight
2019-09-24 開始されました Evercore ISI Outperform
すべてを表示

10 X Genomics Inc (TXG) 最新ニュース

pulisher
Aug 11, 2026

10x Genomics, Inc. (TXG) Stock Analysis: Navigating the High Valuation and Market Dynamics - DirectorsTalk Interviews

Aug 11, 2026
pulisher
Aug 10, 2026

Is 10x Genomics Inc (TXG) Overvalued After 12.3% Rally? GF Value - GuruFocus

Aug 10, 2026
pulisher
Aug 10, 2026

10x Genomics, Inc. (TXG) stock price, news, quote and history - Yahoo Finance UK

Aug 10, 2026
pulisher
Aug 10, 2026

10x Genomics (NASDAQ:TXG) Trading Up 7.1%Time to Buy? - MarketBeat

Aug 10, 2026
pulisher
Aug 10, 2026

TXG Stock Jumps As Earnings Beat Triggers Analyst Upgrades - stockstotrade.com

Aug 10, 2026
pulisher
Aug 10, 2026

10X GENOMICS INC : CANACCORD GENUITY RAISES TARGET PRICE TO $60 FROM $50 - Bitget

Aug 10, 2026
pulisher
Aug 09, 2026

10x Genomics Stock Jumps As Analysts Hike Price Targets - timothysykes.com

Aug 09, 2026
pulisher
Aug 09, 2026

10X Genomics Inc (TXG) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Aug 09, 2026
pulisher
Aug 08, 2026

Enterprise value to EBIT forward of 10x Genomics Inc Class A – BMV:TXG - TradingView

Aug 08, 2026
pulisher
Aug 08, 2026

Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN), 10x Genomics (TXG) and Teleflex (TFX) - The Globe and Mail

Aug 08, 2026
pulisher
Aug 08, 2026

TXG Jumps As 10x Genomics Price Targets Surge After Q2 Beat - timothysykes.com

Aug 08, 2026
pulisher
Aug 07, 2026

10X Genomics Inc (TXG) Stock News Today - TradingKey

Aug 07, 2026
pulisher
Aug 07, 2026

10x Genomics, Inc. Stock 12‑Month Price Target Raised to $47.23, Implies 4% Upside - TradingView

Aug 07, 2026
pulisher
Aug 07, 2026

10x Genomics Q2 Earnings Call Highlights - MarketBeat

Aug 07, 2026
pulisher
Aug 07, 2026

10x Genomics stock hits 52-week high at 50.36 USD - Investing.com

Aug 07, 2026
pulisher
Aug 07, 2026

10x Genomics Q2 Earnings & Revenues Beat Estimates, Gross Margin Up - finance.yahoo.com

Aug 07, 2026
pulisher
Aug 07, 2026

10X GENOMICS, INC. : JEFFERIES RAISES TARGET PRICE TO $53 FROM $40 - moomoo.com

Aug 07, 2026
pulisher
Aug 07, 2026

10x Genomics, Inc. Q2 2026 Earnings Call Summary - finance.yahoo.com

Aug 07, 2026
pulisher
Aug 07, 2026

10x Genomics (NASDAQ: TXG) grows consumables, ends Q2 with $502M cash - Stock Titan

Aug 07, 2026
pulisher
Aug 07, 2026

10x Genomics, Inc. 2026: Revenue $151.04M, EPS ($0.14) — 10-Q Summary - TradingView

Aug 07, 2026
pulisher
Aug 07, 2026

10x Genomics $TXG Shares Sold by Janus Henderson Group PLC - MarketBeat

Aug 07, 2026
pulisher
Aug 07, 2026

TXG|10X Genomics Inc|Price:58.260|Chg%:+6.230 - TradingKey

Aug 07, 2026
pulisher
Aug 07, 2026

Has 10x Genomics Inc (TXG) Missed Earnings Expectations with Q2 - GuruFocus

Aug 07, 2026
pulisher
Aug 07, 2026

10x Genomics (NASDAQ:TXG) Posts Quarterly Earnings Results, Beats Expectations By $0.10 EPS - MarketBeat

Aug 07, 2026
pulisher
Aug 06, 2026

Earnings call transcript: 10x Genomics tops Q2 2026 estimates, shares fall - Investing.com

Aug 06, 2026
pulisher
Aug 06, 2026

Transcript : 10x Genomics, Inc., Q2 2026 Earnings Call, Aug 06, 2026 - marketscreener.com

Aug 06, 2026
pulisher
Aug 06, 2026

10x Genomics Inc (TXG) Shares Fall 3.9% -- What GF Score of 58 T - GuruFocus

Aug 06, 2026
pulisher
Aug 06, 2026

10x Genomics’s (NASDAQ:TXG) Q2 CY2026: Strong Sales, Full-Year Outlook Slightly Exceeds Expectations - finance.yahoo.com

Aug 06, 2026
pulisher
Aug 06, 2026

10x Genomics (TXG) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - finance.yahoo.com

Aug 06, 2026
pulisher
Aug 06, 2026

10x Genomics (TXG) Reports Q2 Loss, Tops Revenue Estimates - finance.yahoo.com

Aug 06, 2026
pulisher
Aug 06, 2026

10x Genomics falls 2% despite beating revenue estimates - Investing.com

Aug 06, 2026
pulisher
Aug 06, 2026

10x Genomics, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 06, 2026
pulisher
Aug 06, 2026

(TXG) 10x Genomics Now Expects 2026 Revenue Range $610M-$630M, vs. FactSet Est of $613.7M - marketscreener.com

Aug 06, 2026
pulisher
Aug 06, 2026

Q2 2026 10X Genomics Inc Earnings Call Transcript - GuruFocus

Aug 06, 2026
pulisher
Aug 06, 2026

10x Genomics Q2 2026: Revenue $151.0M, Gross Margin 74%, Raises 2026 Revenue Guide - TradingView

Aug 06, 2026
pulisher
Aug 06, 2026

10x Genomics: Q2 Earnings Snapshot - AOL.com

Aug 06, 2026
pulisher
Aug 06, 2026

Earnings Flash (TXG) 10x Genomics, Inc. Reports Q2 Revenue $151.0M, vs. FactSet Est of $146.7M - marketscreener.com

Aug 06, 2026
pulisher
Aug 06, 2026

10x Genomics (NASDAQ: TXG) swings to Q2 loss but lifts 2026 revenue guide - Stock Titan

Aug 06, 2026
pulisher
Aug 06, 2026

10x Genomics Reports Second Quarter 2026 Financial Results - marketscreener.com

Aug 06, 2026
pulisher
Aug 06, 2026

10x Genomics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 06, 2026
pulisher
Aug 06, 2026

10X Genomics faces earnings test as revenue expected to decline By Investing.com - Investing.com Nigeria

Aug 06, 2026
pulisher
Aug 06, 2026

10x Sued Over Spatial Genomics Patents by Caltech, Licensee (1) - Bloomberg Law News

Aug 06, 2026
pulisher
Aug 06, 2026

10x Genomics (TXG) 10K Form and Latest SEC Filings 2026 - MarketBeat

Aug 06, 2026
pulisher
Aug 04, 2026

10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect - The Globe and Mail

Aug 04, 2026
pulisher
Aug 04, 2026

10x Genomics, Inc. (TXG) - DirectorsTalk Interviews

Aug 04, 2026
pulisher
Aug 04, 2026

58,083 Shares in 10x Genomics $TXG Acquired by Edgestream Partners L.P. - MarketBeat

Aug 04, 2026
pulisher
Aug 01, 2026

Lazard Asset Management LLC Sells 45,761 Shares of 10x Genomics $TXG - MarketBeat

Aug 01, 2026
pulisher
Aug 01, 2026

10x Genomics (TXG) Teams Up With Lausanne Hospital To Push Cancer Diagnostics Forward - finance.yahoo.com

Aug 01, 2026
pulisher
Jul 31, 2026

Enterprise value to revenue forward of 10x Genomics, Inc. – NASDAQ:TXG - TradingView

Jul 31, 2026
pulisher
Jul 30, 2026

10x Genomics Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs

Jul 30, 2026
pulisher
Jul 30, 2026

10x Genomics $TXG Shares Sold by Renaissance Technologies LLC - MarketBeat

Jul 30, 2026

10 X Genomics Inc (TXG) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

10 X Genomics Inc (TXG) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Saxonov Serge
Chief Executive Officer
Jun 22 '26
Sale
34.44
30,000
1,033,269
1,108,380
SULIMAN SHEHNAAZ
Director
Jun 16 '26
Sale
32.63
5,723
186,756
31,722
$89.01
price down icon 2.80%
HQY HQY
$105.57
price down icon 1.14%
TEM TEM
$55.69
price up icon 1.14%
$26.11
price up icon 1.87%
WAY WAY
$24.30
price down icon 1.62%
大文字化:     |  ボリューム (24 時間):